Candriam S.C.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001537014

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeTechnology TiltHigh Turnover how tags are computed

Q4 2024 · 647 positions · Total reported value $16.89B · Top-10 concentration 31.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.4% · 21 new · 252 cut · 51 exited

Active Share (vs S&P 500): 37.1% · vs QQQ: 52.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.6% · vs SPY -2.8% · Prev Value $22.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $22.25B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Candriam S.C.A. disclosed 647 equity positions with a combined reported value of $16.89B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 31.4% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were MSFT ($1.12B), NVDA ($948.23M), AAPL ($888.46M). By sector, the heaviest allocations are Technology 37.7%, Health Care 20.2%. Versus the prior quarter, allocation shifted toward Technology (+2.6pp), Financials (+2.0pp) and away from Other (-0.9pp), Health Care (-4.0pp).

Versus the prior quarter, Candriam S.C.A. opened 21 new positions, trimmed 252 and fully exited 51, a turnover rate of 47.4% of positions. The portfolio's overlap with the prior quarter was 87% of names.

The largest new positions opened in Q4 2024 were LRCX ($49.52M), FUTU ($28.00M), QFIN ($27.18M).

Of the 51 positions fully exited versus the prior quarter, the largest were BZ ($22.51M), PK ($21.73M), KROS ($20.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • LRCX LAM RESEARCH · $49.52M
  • FUTU FUTU HLDGS LTD · $28.00M
  • QFIN QFIN HOLDINGS INC · $27.18M
  • BLK BLACKROCK INC · $13.28M
  • TERN TERNS PHARMACEUTICALS INC · $11.93M
  • BAP CREDICORP LTD · $11.35M
  • MNSO MINISO GROUP HLDG LTD · $9.99M
  • RL RALPH LAUREN CORP · $9.93M

Fully Exited (vs previous quarter)

  • BZ KANZHUN LIMITED · prev qtr: $22.51M
  • PK PARK HOTELS & RESORTS INC · prev qtr: $21.73M
  • KROS KEROS THERAPEUTICS INC · prev qtr: $20.06M
  • HASI HA SUSTAINABLE INFRA CAP INC · prev qtr: $16.85M
  • AMRC AMERESCO INC · prev qtr: $15.88M
  • LBPH LONGBOARD PHARMACEUTICALS IN · prev qtr: $12.02M
  • ONTO ONTO INNOVATION INC · prev qtr: $10.81M
  • EHC ENCOMPASS HEALTH CORP · prev qtr: $8.02M

Insider Transactions (Form 4)

Latest Candriam S.C.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Candriam S.C.A. is a Luxembourg-based asset management firm founded in 1989, now part of New York Life Investments, with headquarters in Strassen, Luxembourg. The firm employs a responsible investment approach integrating ESG factors across various asset classes.

Investment Approach

Responsible investment with ESG integration, combining quantitative and fundamental research, offering both active and passive investment strategies

Asset Classes

Equities, fixed income, alternatives, multi-asset solutions

Notable Facts

Part of New York Life Investments, strong focus on sustainable investing, acquired in 2018

AUM

$154.7B (SEC Form ADV regulatory figure)

Official disclosures available through SEC filings

Sector Allocation

Technology 37.7%
Health Care 20.2%
Financials 9.1%
Utilities 2.6%
Other 5.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.67M $1.12B 6.66%
6.66%
Add
2 7.06M $948.23M 5.61%
5.61%
Add
3 3.55M $888.46M 5.26%
5.26%
Hold
4 2.76M $523.30M 3.10%
3.10%
Reduce
5 2.02M $444.00M 2.63%
2.63%
Add
6 524.21K $404.69M 2.40%
2.40%
Add
7 515.59K $271.50M 1.61%
1.61%
Add
8 1.13M $262.34M 1.55%
1.55%
Add
9 663.88K $221.95M 1.31%
1.31%
Add
10 2.22M $220.59M 1.31%
1.31%
Reduce
11 407.49K $211.99M 1.25%
1.25%
Add
12 1.26M $210.85M 1.25%
1.25%
Add
13 607.15K $191.88M 1.14%
1.14%
Reduce
14 379.18K $191.81M 1.14%
1.14%
Reduce
15 470.99K $190.21M 1.13%
1.13%
Add
16 261.50K $186.27M 1.10%
1.10%
Add
17 916.27K $184.89M 1.09%
1.09%
Add
18 763.52K $183.02M 1.08%
1.08%
Add
19 941.07K $179.22M 1.06%
1.06%
Reduce
20 868.11K $171.44M 1.01%
1.01%
Hold
21 617.52K $160.95M 0.95%
0.95%
Reduce
22 1.72M $159.18M 0.94%
0.94%
Reduce
23 135.74K $143.90M 0.85%
0.85%
Reduce
24 363.69K $141.47M 0.84%
0.84%
Add
25 1.13M $140.12M 0.83%
0.83%
Add
26 247.63K $129.25M 0.77%
0.77%
Add
27 191.42K $112.08M 0.66%
0.66%
Add
28 258.62K $104.15M 0.62%
0.62%
Reduce
29 340.96K $101.20M 0.60%
0.60%
Add
30 823.35K $99.45M 0.59%
0.59%
Reduce
31 846.93K $96.51M 0.57%
0.57%
Reduce
32 855.37K $94.48M 0.56%
0.56%
Add
33 310.14K $91.67M 0.54%
0.54%
Add
34 596.70K $91.67M 0.54%
0.54%
Reduce
35 297.39K $89.35M 0.53%
0.53%
Reduce
36 707.75K $88.98M 0.53%
0.53%
Add
37 1.05M $88.38M 0.52%
0.52%
Add
38 466.02K $88.35M 0.52%
0.52%
Add
39 365.23K $87.51M 0.52%
0.52%
Add
40 1.98M $87.04M 0.52%
0.52%
Add
41 1.51M $85.21M 0.50%
0.50%
Add
42 498.37K $81.20M 0.48%
0.48%
Reduce
43 348.89K $80.09M 0.47%
0.47%
Reduce
44 885.01K $79.96M 0.47%
0.47%
Add
45 341.17K $79.94M 0.47%
0.47%
Hold
46 646.23K $78.07M 0.46%
0.46%
Add
47 668.68K $77.58M 0.46%
0.46%
Add
48 414.84K $73.72M 0.44%
0.44%
Add
49 450.30K $73.23M 0.43%
0.43%
Reduce
50 14.53K $72.18M 0.43%
0.43%
Reduce

FAQ

What did Candriam S.C.A. buy in 2024-Q4?

In its 2024-Q4 13F filing, Candriam S.C.A. reported 647 equity positions worth $16.89B in aggregate; its largest disclosed positions were MSFT ($1.12B), NVDA ($948.23M), AAPL ($888.46M).

How large is Candriam S.C.A.'s portfolio?

Candriam S.C.A. reported $16.89B of long equity holdings across 647 positions as of 2024-Q4. Top-10 holdings account for 31.4% of reported value.

What is Candriam S.C.A.'s investment style?

HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/candriam-s-c-a/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →